HP4-31351-66323
2 vaccinations
3 coded responses
17 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 118 / NY
- Registered
- 2022-10-28
- Relationship
- Child or adolescent in my care
- Guardian
- ADK-19164-59606
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-10-18
Dose 1 — Pfizer-BioNTech
-
2022-10-28
Registered in v-safe
- 2022-10-28
- 2022-11-01
- 2022-11-08
- 2022-11-15
- 2022-11-22
-
2022-11-26
Dose 2 — Pfizer-BioNTech
- 2022-11-29
- 2022-11-30
-
2022-12-01
Survey response — days 1–6 daily, dose 2, under 3MedDRA: Dysphonia, Rhinorrhoea — Feeling: Fair · FeverFree text: Sniffles. Nasally voice.MedDRA releases: 2024-11 · check-in free text available
-
2022-12-02
Survey response — days 1–6 daily, dose 2, under 3MedDRA: Nasopharyngitis, Rhinorrhoea — Feeling: Good · FeverFree text: Sniffling. Mild cold symptoms.MedDRA releases: 2024-11 · check-in free text available
-
2022-12-03
Health check-in — day 7, dose 2, under 3Feeling: Fair · Fever · Irritability/cryingUnder 3 check-in
- 2022-12-10
- 2022-12-17
- 2022-12-24
- 2022-12-31
-
2023-01-07
Survey response — day 42, dose 2, under 3MedDRA: SARS-CoV-2 test positive — Feeling: Good · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
- 2023-02-27
- 2023-05-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-10-18 | Pfizer-BioNTech | No |
| 2 | 2022-11-26 | Pfizer-BioNTech | No |
Free text
Release 12 (Under 3) — days 1–6 daily, dose 2, under 3
Systemic reaction (other): Sniffles. Nasally voice.
Systemic reaction (other): Sniffling. Mild cold symptoms.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SRO | Dysphonia | · | · | ✓ |
| SRO | Nasopharyngitis | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release